Ethical issues in research relationships between universities and industry¹

This a report of a symposium that was held November 3,4 1995 in Baltimore Maryland. It was sponsored by the University of Maryland at Baltimore Center for Biomedical Ethics and supported by Friends, Research Institute Inc., Towson, MD. The Planning Committee included: James T. Rule, DDS, Acting Director, Center for Biomedical Ethics at UMAB and Professor, UMAB Dental School, Program Chairman; J. Leslie Glick, PhD, Graduate School of Management and Technology, UM University College; Thomas E. Hanlon, PhD, UMAB School of Medicine; Madison Powers, JD, PhD, Kennedy Institute of Ethics and Georgetown U.; M. Virginia Ruth, Dr PH, RN, UMAB School of Nursing; Mark Sargent JD, UMAB School of Law; Adil E. Shamoo, PhD, UMAB School of Medicine. Speakers and Panelists included: Lawrence K. Altanan, MD, Medical Correspondent, The New York Times; Frederick Betz, PhD, Program Officer, NSF; David Blumenthal, MD, MPP, Chief, Health Policy, Massachusetts General Hospital; Joann A. Boughman, PhD, Vice President, Academic Affairs, UMAB; Robert P. Charrow, JD, Crowell & Moring, Washington, DC; Cynthia Crossen, Marketplace Editor, Wall Street Journal; Edward E. David Jr., PhD, President of EED Inc, Former Science Advisor of the President of the United States, Former President of Exxon Research, Former Executive Director of Bell Laboratories; Michael Davis, PhD, Senior Research Associate, Center for Study of Ethics in the Professions, Illinois Institute of Technology; V.M. Esposito, PhD, Chairman and CEO, MicroCarb Inc.; Mark S. Frankel, PhD, Director, Scientific Freedom, Responsibility and Law Program, AAAS; George J. Galasso, PhD, Associate Director, NIH; J. Leslie Glick, PhD, Editor‐in‐Chief, Technology Management; Allan L. Goldstein, PhD, Professor and Chair, Department of Biochemistry and Molecular Biology, George Washington University Medical Center; A. Arthur Gottlieb, MD, Professor and Chair, Department of Microbiology and Immunology, Tulane University School of Medicine; Ruth L. Greenstein, JD, Vice President for Administration and Finance, Institute for Defense Analyses, Alexandria, VA.; Sheldon Krimsky PhD, Professor, Department of Urban and Environmental Policy, Tufts University; Roland W. Schmitt, PhD, President Emeritus, Rensselaer Polytechnic Institute, Senior Vice President (Ret.), Science & Technology, General Electric, Chairman, Board of Governors, American Institute of Physics; Adil E. Shamoo, PhD, Editor‐in‐Chief, Accountability in Research; Edmund C. Tramont, MD, Professor and Director, Medical Biotechnology Center, University of Maryland Biotechnology Center; Steven S. Wasserman, PhD, Senior Research Coordinator, Center for Vaccine Development, UMAB.

Click to increase image sizeClick to decrease image size

Notes

This a report of a symposium that was held November 3,4 1995 in Baltimore Maryland. It was sponsored by the University of Maryland at Baltimore Center for Biomedical Ethics and supported by Friends, Research Institute Inc., Towson, MD. The Planning Committee included: James T. Rule, DDS, Acting Director, Center for Biomedical Ethics at UMAB and Professor, UMAB Dental School, Program Chairman; J. Leslie Glick, PhD, Graduate School of Management and Technology, UM University College; Thomas E. Hanlon, PhD, UMAB School of Medicine; Madison Powers, JD, PhD, Kennedy Institute of Ethics and Georgetown U.; M. Virginia Ruth, Dr PH, RN, UMAB School of Nursing; Mark Sargent JD, UMAB School of Law; Adil E. Shamoo, PhD, UMAB School of Medicine. Speakers and Panelists included: Lawrence K. Altanan, MD, Medical Correspondent, The New York Times; Frederick Betz, PhD, Program Officer, NSF; David Blumenthal, MD, MPP, Chief, Health Policy, Massachusetts General Hospital; Joann A. Boughman, PhD, Vice President, Academic Affairs, UMAB; Robert P. Charrow, JD, Crowell & Moring, Washington, DC; Cynthia Crossen, Marketplace Editor, Wall Street Journal; Edward E. David Jr., PhD, President of EED Inc, Former Science Advisor of the President of the United States, Former President of Exxon Research, Former Executive Director of Bell Laboratories; Michael Davis, PhD, Senior Research Associate, Center for Study of Ethics in the Professions, Illinois Institute of Technology; V.M. Esposito, PhD, Chairman and CEO, MicroCarb Inc.; Mark S. Frankel, PhD, Director, Scientific Freedom, Responsibility and Law Program, AAAS; George J. Galasso, PhD, Associate Director, NIH; J. Leslie Glick, PhD, Editor‐in‐Chief, Technology Management; Allan L. Goldstein, PhD, Professor and Chair, Department of Biochemistry and Molecular Biology, George Washington University Medical Center; A. Arthur Gottlieb, MD, Professor and Chair, Department of Microbiology and Immunology, Tulane University School of Medicine; Ruth L. Greenstein, JD, Vice President for Administration and Finance, Institute for Defense Analyses, Alexandria, VA.; Sheldon Krimsky PhD, Professor, Department of Urban and Environmental Policy, Tufts University; Roland W. Schmitt, PhD, President Emeritus, Rensselaer Polytechnic Institute, Senior Vice President (Ret.), Science & Technology, General Electric, Chairman, Board of Governors, American Institute of Physics; Adil E. Shamoo, PhD, Editor‐in‐Chief, Accountability in Research; Edmund C. Tramont, MD, Professor and Director, Medical Biotechnology Center, University of Maryland Biotechnology Center; Steven S. Wasserman, PhD, Senior Research Coordinator, Center for Vaccine Development, UMAB.